Niners EDGE Nick Bosa (groin) is questionable for Sunday's game against the Falcons. DL Arik Armstead (foot, ankle) and DT Javon Kinlaw (knee) are out. Bosa missed the week's 1st 2 practices after leaving last week's win over the Panthers early. He returned for a limited Friday workout. We'll check his status Sunday.
ESPN's Adam Schefter reports that 49ers EDGE Nick Bosa (hamstring) "will play" today vs. the Buccaneers. That's significant for both IDP lineups and the 49ers' team defense. Bosa did sit out of practice all week, but he's still worth betting on for your fantasy football lineup. We've seen him effectively play through hamstring injuries before.
Niners EDGE Nick Bosa (hamstring) is questionable for Sunday's game against the Buccaneers. We'll track his status over the weekend. Bosa is generally worth waiting for in IDP lineups if he has a shot to play.
Niners EDGE Nick Bosa is off the injury report and ready to play Sunday's game against the Chiefs. S Talanoa Hufanga (concussion) is questionable. He managed just a single limited practice and seems unlikely to play. CB Charvarius Ward (groin) is questionable as well. The 49ers have ruled DL Arik Armstead (foot, ankle) out.
Niners EDGE Nick Bosa (groin) is inactive for today's game against the Falcons.
Niners HC Kyle Shanahan says EDGE Nick Bosa has a groin strain, according to ESPN's Nick Wagoner. He'll be re-evaluated Wednesday, we assume to determine whether Bosa will be ready to practice and/or play this week. We'll watch for further updates, but it continues to sound like a minor injury.
Based on our award-winning projections, an axis of data points give insights far deeper than a ranking
Round-by-Round Draft Strategy Guides, Sleepers, Undervalued Players, Busts and Handcuffs
Command your entire draft with a dynamic tool synced to your league. Updating and adapting in real time.
Quickly find the free-agent gems, pull the trigger on the perfect trade & make the right start/sit decisions.
$6/month thereafter, billed semi-annually, one-click cancel anytime.
Follow us on